Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
  1. 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 12,894 shares (to pay taxes)
  2. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 48,043 shares (to pay taxes)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $77.07 ($3,853,503)
  8. 4 Grant or award Director acquired 889 shares (grant or award)
  9. 4 Planned sale Director sold 2,000 shares at $70.25 ($140,500)
  10. 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 4,243 shares (to pay taxes)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale SVP, CHIEF OPERATING OFFICER sold 4,263 shares at $65.19 ($277,905)
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale Director sold 829 shares at $71.60 ($59,356)
  15. 4 Planned sale PRESIDENT AND CEO sold 16,569 shares at an average $68.92 ($1,141,925)
  16. 4 Planned sale PRESIDENT AND CEO sold 60,000 shares at an average $69.47 ($4,167,930)
  17. 4 Planned sale Director sold 2,000 shares at $68.48 ($136,960)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Planned sale PRESIDENT AND CEO sold 60,000 shares at an average $71.86 ($4,311,745)

Page 3 of 39 · 774 filings